Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

Rick A. Bright(Waterford Institute), Jacqueline M. Katz(National Center for Immunization and Respiratory Diseases), Ted M. Ross(Cleveland Clinic), Harriet L. Robinson(GeoVax (United States)), Kanta Subbarao(Peter Doherty Institute)
Virology
April 1, 2003
Cited by 62


Related Papers